Refine
Has Fulltext
- yes (40)
Is part of the Bibliography
- yes (40)
Year of publication
Document Type
- Journal article (40) (remove)
Language
- English (40) (remove)
Keywords
- Biochemie (17)
- MYCN (3)
- Wilms tumor (3)
- nephroblastoma (3)
- Wilms tumour (2)
- miRNA (2)
- molecular biology (2)
- paediatric cancer (2)
- Allelic loss (1)
- Amplification (1)
- Biologie (1)
- Children (1)
- DNA metabolism (1)
- DNA methylation (1)
- DNA-binding proteins (1)
- Deletion analysis (1)
- Drosha (1)
- Event (1)
- Gene (1)
- Genom / Genkartierung / Genanalyse (1)
- Heparan-sulfate (1)
- Krebs (1)
- Locus (1)
- Lung-cancer (1)
- MAX (1)
- Mechanisms (1)
- Mutation screening (1)
- Mutations (1)
- N-Myc (1)
- Nephroblastoma (1)
- Neuro-blastoma (1)
- Poor-prognosis (1)
- Relapse (1)
- Reveals (1)
- SSCP analysis (1)
- Serum autoantibodies (1)
- Suppressors EXT1 (1)
- T cells (1)
- TP53 (1)
- Therapy (1)
- Tumor suppressor gene (1)
- WTI (1)
- Wilms' tumor (1)
- Zinc finger gene (1)
- alagille syndrome (1)
- anaplasia (1)
- aortic-valve (1)
- axial skeletal defects (1)
- beta-catenin (1)
- biological sciences (1)
- blastemal (1)
- c-src (1)
- cancer (1)
- cancer genomics (1)
- cancer predisposition syndromes (1)
- cell proliferation (1)
- clinical malformations (1)
- copy number (1)
- developmental biology (1)
- differentiation (1)
- expression (1)
- gain (1)
- gene (1)
- genetics (1)
- glycerol (1)
- histology (1)
- human jagged1 (1)
- immunoprecipitation (1)
- integrative genomics viewer (1)
- interactome (1)
- lipidomics (1)
- mice (1)
- mutation screening (1)
- mutations (1)
- nephroblastomatosis (1)
- oncogene amplification (1)
- oncogenesis (1)
- osteoblast differentiation (1)
- outcome (1)
- pathology (1)
- predictive markers (1)
- primary tumor cell culture (1)
- prognostic marker (1)
- protein domains (1)
- protein interactions (1)
- protein tyrosine kinase (1)
- protooncogene (1)
- regressive (1)
- renal cancer (1)
- retinoic acid (1)
- reveals (1)
- sequencing data (1)
- somatic mutations (1)
- transcription factor (1)
- transcription factors (1)
- translational research (1)
- tumor model (1)
- tumor surveillance (1)
- tumour heterogeneity (1)
- ubiquitination (1)
Institute
The human gene encoding the myogenic determination factor myf3 (mouse MyoD1) has been mapped to the short arm of chromosome 11. Analysis of several somatic cell hybrids containing various derivatives with deletions or translocations revealed that the human MyoD (MYF3) gene is not associated with the WAGR locus at chromosomal band 11pl3 nor with the loss of the heterozygosity region at 11p15.5 related to the Beckwith-Wiedemann syndrome. Subregional mapping by in situ hybridization with an myf3 specific probe shows that the gene resides at the chromosomal band llp14, possibly at llp14.3.
A long-range restriction map of part of the short arm of ehromosome 11 including the WAGR region has been constructed using pulsed-field gel electrophoresis and a number of infrequently cutting restriction enzymes. A total of 15.4 Mbp has been mapped in detall, extending from proximal 11p14 to the distal part of 11p12. The map localizes 35 different DNA probes and reveals at least nine areas with features eharaeteristle of BTF islands, some of which may be candidates for the different loci underlying the phenotype of the WAGR syndrome. This map will furthermore allow screening of DNA from individuals with WAGR-related phenotypes and from Wilms tumors for associated chromosomal rearrangements.
The WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) region has been assigned to chromosome 11p13 on the basis of overlapping constitutional deletions found in affected individuals. We have utilized 31 DNA probes which map to the WAGR deletion region, together with six reference loci and 13 WAGR-related deletions, to subdivide this area into 16 intervals. Specific intervals have been correlated with phenotypic features, leading to the identification of individual subregions for the aniridia and Wilms tumor loci. Delineation, by specific probes, of multiple intervals above and below the critical region and of five intervals within the overlap area provides a framework map for molecular characterization of WAGR gene loci and of deletion boundary regions.
Chromosome 11p13 is frequently rearranged in individuals with the WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) or parts of this syndrome. To map the cytogenetic aberrations molecularly, we screened DNA from cell Unes with known WAGR-related chromosome abnormalities for rearrangements with pulsed fleld gel (PFG) analysis using probes deleted from one chromosome 11 homolog of a WAGR patient. The first alteration was detected in a cell line from an individual with aniridia, genitourinary anomalies, mental retardation, and a deletion described as 11p14.1-p13. We have located one breakpoint close to probe HU11-164B and we have cloned both breakpoint sites as well as the junctional fragment. The breakpoints subdivide current intervals on the genetic map, and the probes for both sides will serve as important additional markers for a long-range restriction map of this region. Further characterization and sequencing of the breakpoints may yield insight into the mechanisms by which these deletions occur.
Activation of the pp60\(^{c-src}\) kinase during differentiation of monomyelocytic cells in vitro
(1986)
Tbe proto-oncogene c-src, the cellular homolog of the Rous sarcoma virus (RSV) transforming gene v-src, is expressed in a tissue-specific and age-dependent manner. Its physiological function, although still unknown, appears to be more closely related to differentiation processes than to proliferation processes. To obtain more information about the physiological role of the c-src gene in cells, we have studied differentiation-dependent alterations using the human HL-60 leukaemia cell line as a model system. Induction of monocytic and granulocytic differentiation of HL-60 cells by 12-0-tetradecanoylphorbol-13-acetate (TPA) and dimethylsulfoxide (DMSO) is associated with an activation of the pp60<sup>c-src</sup> tyrosine kinase, but not with increased c-src gene expression. Control experiments exclude an interaction of TPA and DMSO themselves with the pp60<sup>c-src</sup> kinase.
The cellular onc-genes c-src and c-yes are expressed very differently during chicken embryonic development. The c-src mRNA and its translational product are detectable at high levels in brain extracts of chicken embryos and adult chickens, whereas muscle extracts show an age-dependent decrease in the amounts of c-src-specific mRNA and pp60<sup>c-src</sup> kinase activity. In contrast, the Ievels of c-yes mRNA in brain, heart, and muscle are relatively low in early embryonic stages and increase later on to values comparable to those found for liver, while in adult animals the pattern of c-yes expression is similar to that of the c-src gene. From the close correlation between the Ievels of pp60<sup>c-src</sup>, its enzymatic activity, and its corresponding mRNA at a given stage of development and in given tissues, it appears that the expression of pp60<sup>c-src</sup> is primarily controlled at the level of transcription. It is suggested that because of the different patterns of expression, the two cellular oncogenes, c-src and c-yes, play different roles in cell proliferation during early embryonic stages as weil as in ensuing differentiation processes.